Double-blind Randomised Phase I/IIb Study
Phase of Trial: Phase I/II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Trastuzumab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Pharmacokinetics
- Acronyms Compare
- 11 Feb 2015 Planned End Date changed from 1 Jun 2013 to 1 Dec 2017 according to ClinicalTrials.gov record.
- 04 Jun 2013 Status changed from active, no longer recruiting to completed.
- 04 Jun 2013 Pooled analysis presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History